Treace Medical Concepts Inc expected to post a loss of 4 cents a share - Earnings Preview

Treace Medical Concepts

25/02/2025 22:01

Treace Medical Concepts Inc TMCI.OQ TMCI.O is expected to show a rise in quarterly revenue when it reports  results on February 27 for the period ending December 31 2024

The Ponte Vedra Florida-based  company is expected to report a 7.9% increase in revenue to $67.157 million from $62.21 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on January 13 2025, for the period ended December 31, was for revenue between $68.40 million and $68.80 million.

‚ÄčLSEG's mean analyst estimate for Treace Medical Concepts Inc is for a loss of 4 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Treace Medical Concepts Inc is $8.20‚Äč, below‚Äč its last closing price of $9.59. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.27
-0.27
-0.25
Beat
8
Jun. 30 2024
-0.29
-0.29
-0.29
Met
0
Mar. 31 2024
-0.30
-0.30
-0.30
Met
0.9‚Äč
Dec. 31 2023
-0.09
-0.09
-0.10
Missed
-12.9
‚Äč‚ÄčSep. 30 2023
-0.25
-0.26
-0.28
Missed
-7.1
Jun. 30 2023
-0.23
-0.24
-0.20
Beat
16.1‚Äč
Mar. 31 2023
-0.23
-0.23
-0.23
Met
-0.7
Dec. 31 2022
-0.15
-0.14
-0.08
Beat
42.9

This summary was machine generated February 25 at 22:01 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)